» Authors » E J Rutgers

E J Rutgers

Explore the profile of E J Rutgers including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 94
Citations 978
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
van Rossum A, Kok M, van Werkhoven E, Opdam M, Mandjes I, van Leeuwen-Stok A, et al.
Eur J Cancer . 2018 Aug; 102:40-48. PMID: 30125761
Background: Dose-dense administration of chemotherapy and the addition of taxanes to anthracycline-based adjuvant chemotherapy have improved breast cancer survival substantially. However, clinical trials directly comparing the additive value of taxanes...
2.
Viale G, de Snoo F, Slaets L, Bogaerts J, van t Veer L, Rutgers E, et al.
Breast Cancer Res Treat . 2017 Sep; 167(1):123-131. PMID: 28929359
Purpose: This study compares immunohistochemical (IHC) versus molecular subtyping (BluePrint and MammaPrint) in the population of patients enrolled in MINDACT and outcome based on molecular subtyping (MS) versus surrogate pathological...
3.
Aalders K, Kuijer A, Straver M, Slaets L, Litiere S, Viale G, et al.
Eur J Cancer . 2017 May; 79:98-105. PMID: 28477490
Background: In multifocal breast cancer, guidelines recommend basing adjuvant systemic treatment decisions on characteristics of the largest lesion, disregarding multifocality as an independent prognosticator. We assessed the association between multifocal...
4.
Bosma S, van der Leij F, van Werkhoven E, Bartelink H, Wesseling J, Linn S, et al.
Breast Cancer Res Treat . 2016 Mar; 156(2):391-400. PMID: 27008183
The purpose of this study was to study the impact of changes in clinical practice on outcome in patients treated with breast-conserving therapy (BCT) over a period of 28 years....
5.
Koolen B, Aukema T, Gonzalez Martinez A, Vogel W, Caballero Ontanaya L, Vrancken Peeters M, et al.
Q J Nucl Med Mol Imaging . 2013 Mar; 57(1):92-100. PMID: 23474637
Aim: Recently, a high-resolution dedicated PET system for hanging breast imaging (MAMMI PET) has been developed to improve primary tumor detection and characterization. The aim of this pilot study was...
6.
Mook S, Bonnefoi H, Pruneri G, Larsimont D, Jaskiewicz J, Sabadell M, et al.
Eur J Cancer . 2009 Feb; 45(7):1201-1208. PMID: 19232484
Purpose: The 70-gene prognosis-signature is a prognostic tool for early breast cancer analysis. In addition to scientific evidence, implementation of the signature in clinical trials and daily practice requires logistical...
7.
Aukema T, Russell N, Wesseling J, Rutgers E
Eur J Surg Oncol . 2009 Jan; 35(5):469-74. PMID: 19176274
Introduction: Locoregional breast cancer recurrence can be detected at an advanced stage of the disease. To achieve local control for these larger local breast cancer recurrences, wide soft tissue resections...
8.
Pengel K, Loo C, Teertstra H, Muller S, Wesseling J, Peterse J, et al.
Breast Cancer Res Treat . 2008 Sep; 116(1):161-9. PMID: 18807269
Aim: To assess whether preoperative contrast-enhanced magnetic resonance imaging (MRI) of the breast influences the rate of incomplete tumor excision. Methods: In a cohort of 349 women with invasive breast...
9.
Meijnen P, Peterse J, Nieweg O, Rutgers E
Ned Tijdschr Geneeskd . 2005 Jan; 148(49):2428-32. PMID: 15626306
Staging of the axillary lymph nodes yields important prognostic information in patients with breast cancer. The characteristics of the primary tumour are more significant for prognosis if only micrometastases (diameter...
10.
Weigelt B, Verduijn P, Bosma A, Rutgers E, Peterse H, Vant Veer L
Br J Cancer . 2004 Apr; 90(8):1531-7. PMID: 15083181
Disseminated breast tumour cells in sentinel lymph nodes (SNs) were evaluated by quantitative real-time PCR and the sensitivity of this assay was compared to the routine histological analysis. First, several...